FBLG – fibrobiologics, inc. (US:NASDAQ)
Stock Stats
News
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
FibroBiologics, Inc. (NASDAQ: FBLG) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $16.00 price target on the stock.
FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics [Yahoo! Finance]
FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics
FibroBiologics Announces Scientific Advancement in Confirmation Results of Brain Tissue Repair
Form PRE 14A FibroBiologics, Inc. For: Dec 31
Form 10-K FibroBiologics, Inc. For: Dec 31
Form 4 FibroBiologics, Inc. For: Mar 26 Filed by: Khoja Hamid
Form 4 FibroBiologics, Inc. For: Mar 26 Filed by: GARCIA RUBEN A
Form 4 FibroBiologics, Inc. For: Mar 26 Filed by: O'HEERON PETE
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.